Cogent Biosciences, Inc. · NASDAQ:COGT
BlackRock, Inc. reported a 8.00% stake in Cogent Biosciences, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc. reported a 8.00% stake in Cogent Biosciences, Inc., 13,593,063 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G/A).
- Stake
- 8.00%
- Shares
- 13,593,063
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 8.00% | 13,593,063 |
Source
Related
- Cogent Biosciences, Inc.
- BlackRock, Inc.
- Cogent Biosciences, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G/A · BlackRock, Inc. · Jan 21, 2026
- Form 4 · Morris Arlene · Aug 31, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Robbins Andrew R · May 21, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · May 14, 2026